Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94


The stem cell markers Oct4A, Nanog and c-Myc are expressed in ascites cells and tumor tissue of ovarian cancer patients.

Di J, Duiveman-de Boer T, Zusterzeel PL, Figdor CG, Massuger LF, Torensma R.

Cell Oncol (Dordr). 2013 Oct;36(5):363-74. doi: 10.1007/s13402-013-0142-8. Epub 2013 Aug 9.


Induced overexpression of Oct4A in human dental pulp cells enhances pluripotency and multilineage differentiation capability.

Liu L, Wu L, Wei X, Ling J.

Stem Cells Dev. 2015 Apr 15;24(8):962-72. doi: 10.1089/scd.2014.0388. Epub 2015 Jan 8.


Protein markers of cancer-associated fibroblasts and tumor-initiating cells reveal subpopulations in freshly isolated ovarian cancer ascites.

Wintzell M, Hjerpe E, Åvall Lundqvist E, Shoshan M.

BMC Cancer. 2012 Aug 18;12:359. doi: 10.1186/1471-2407-12-359.


Klf4 transcription factor is expressed in the cytoplasm of prostate cancer cells.

Le Magnen C, Bubendorf L, Ruiz C, Zlobec I, Bachmann A, Heberer M, Spagnoli GC, Wyler S, Mengus C.

Eur J Cancer. 2013 Mar;49(4):955-63. doi: 10.1016/j.ejca.2012.09.023. Epub 2012 Oct 22.


Reduced tumorigenicity and drug resistance through the downregulation of octamer-binding protein 4 and Nanog transcriptional factor expression in human breast stem cells.

Huang ZJ, You J, Luo WY, Chen BS, Feng QZ, Wu BL, Jiang L, Luo Q.

Mol Med Rep. 2015 Mar;11(3):1647-54. doi: 10.3892/mmr.2014.2972. Epub 2014 Nov 18.


Galectin-3 modulates the EGFR signalling-mediated regulation of Sox2 expression via c-Myc in lung cancer.

Kuo HY, Hsu HT, Chen YC, Chang YW, Liu FT, Wu CW.

Glycobiology. 2016 Feb;26(2):155-65. doi: 10.1093/glycob/cwv088. Epub 2015 Oct 6.


Modification of the Tumor Microenvironment in KRAS or c-MYC-Induced Ovarian Cancer-Associated Peritonitis.

Yoshida M, Taguchi A, Kawana K, Adachi K, Kawata A, Ogishima J, Nakamura H, Fujimoto A, Sato M, Inoue T, Nishida H, Furuya H, Tomio K, Arimoto T, Koga K, Wada-Hiraike O, Oda K, Nagamatsu T, Kiyono T, Osuga Y, Fujii T.

PLoS One. 2016 Aug 2;11(8):e0160330. doi: 10.1371/journal.pone.0160330. eCollection 2016.


Differentiation-independent fluctuation of pluripotency-related transcription factors and other epigenetic markers in embryonic stem cell colonies.

Sustáčková G, Legartová S, Kozubek S, Stixová L, Pacherník J, Bártová E.

Stem Cells Dev. 2012 Mar 20;21(5):710-20. doi: 10.1089/scd.2011.0085. Epub 2011 Jul 8.


Oct4A is expressed by a subpopulation of prostate neuroendocrine cells.

Sotomayor P, Godoy A, Smith GJ, Huss WJ.

Prostate. 2009 Mar 1;69(4):401-10. doi: 10.1002/pros.20895.


Prognostic significance of NANOG and KLF4 for breast cancer.

Nagata T, Shimada Y, Sekine S, Hori R, Matsui K, Okumura T, Sawada S, Fukuoka J, Tsukada K.

Breast Cancer. 2014 Jan;21(1):96-101. doi: 10.1007/s12282-012-0357-y. Epub 2012 Apr 17.


The hypoxic microenvironment maintains glioblastoma stem cells and promotes reprogramming towards a cancer stem cell phenotype.

Heddleston JM, Li Z, McLendon RE, Hjelmeland AB, Rich JN.

Cell Cycle. 2009 Oct 15;8(20):3274-84. Epub 2009 Oct 3.


Wnt/β-catenin signaling pathway upregulates c-Myc expression to promote cell proliferation of P19 teratocarcinoma cells.

Zhang S, Li Y, Wu Y, Shi K, Bing L, Hao J.

Anat Rec (Hoboken). 2012 Dec;295(12):2104-13. doi: 10.1002/ar.22592. Epub 2012 Sep 14.


Helicobacter pylori upregulates Nanog and Oct4 via Wnt/β-catenin signaling pathway to promote cancer stem cell-like properties in human gastric cancer.

Yong X, Tang B, Xiao YF, Xie R, Qin Y, Luo G, Hu CJ, Dong H, Yang SM.

Cancer Lett. 2016 May 1;374(2):292-303. doi: 10.1016/j.canlet.2016.02.032. Epub 2016 Mar 2.


Cell fate determination factor Dachshund reprograms breast cancer stem cell function.

Wu K, Jiao X, Li Z, Katiyar S, Casimiro MC, Yang W, Zhang Q, Willmarth NE, Chepelev I, Crosariol M, Wei Z, Hu J, Zhao K, Pestell RG.

J Biol Chem. 2011 Jan 21;286(3):2132-42. doi: 10.1074/jbc.M110.148395. Epub 2010 Oct 11.


A critical role of Oct4A in mediating metastasis and disease-free survival in a mouse model of ovarian cancer.

Samardzija C, Luwor RB, Volchek M, Quinn MA, Findlay JK, Ahmed N.

Mol Cancer. 2015 Aug 11;14:152. doi: 10.1186/s12943-015-0417-y.


Gata4 blocks somatic cell reprogramming by directly repressing Nanog.

Serrano F, Calatayud CF, Blazquez M, Torres J, Castell JV, Bort R.

Stem Cells. 2013 Jan;31(1):71-82. doi: 10.1002/stem.1272.

Supplemental Content

Support Center